Open reduction internal fixation left distal femur fracture with [**Last Name (un) **] plate.
Open reduction internal fixation right distal femur with [**Last Name (un) **] plate.
Open reduction internal fixation right hip fracture with TFN devices, 11 x 170 x 130.
[**2122-10-14**]: Insertion of inferior vena cava filter  [**2122-10-14**]: Percutaneous tracheostomy; Percutaneous endoscopic gastrostomy tube.
Transfer via [**Location (un) **], recv'd fentanyl during xport.
Tobacco/EtOH/Recreational drugs: denies  Family History: Non-contributory  Physical Exam: P/E on D/C: VS: 101.0   98   123/57   29   100% 0.5FM GEN: WD bedbound F in NAD HEENT: +large R frontal subgaleal hematoma; EOMI; PERRLA; +tracheostomy w no erythema/drainage CV: RRR PULM: coarse breath sounds b/l ABD: S/NT/ND; +PEG tube in LUQ w no erythema/drainage; +suprapubic catheter in place EXT: 2+ b/l lower extremity edema; b/l multipodus boots; L knee w staples at anterior incision; B/L lateral thigh incisions w staples in place; all incisions c/d/i w no erythema or drainage NEURO: A&Ox0; opens eyes spontaneously; does not track; does not follow commands; does not vocalize; B/L LE 0/5 strength; UE 1+/5 B/L  Pertinent Results: LABORATORIES: Admit: [**2122-10-7**] 04:40PM BLOOD WBC-40.9* RBC-4.06* Hgb-12.8 Hct-36.2 MCV-89 MCH-31.5 MCHC-35.3* RDW-16.2* Plt Ct-105* [**2122-10-7**] 04:40PM BLOOD PT-13.7* PTT-22.0 INR(PT)-1.2* [**2122-10-7**] 04:40PM BLOOD Glucose-151* UreaN-21* Creat-0.6 Na-143 K-4.0 Cl-111* HCO3-20* AnGap-16 [**2122-10-7**] 04:40PM BLOOD ALT-36 AST-54* AlkPhos-85 TotBili-0.7 [**2122-10-7**] 08:00PM BLOOD CK-MB-8 cTropnT-<0.01 [**2122-10-7**] 04:40PM BLOOD Albumin-3.4* Calcium-7.4* Mg-1.8  Discharge: [**2122-10-20**] 01:42AM BLOOD WBC-17.4* RBC-2.26* Hgb-7.0* Hct-20.7* MCV-92 MCH-31.0 MCHC-33.8 RDW-16.1* Plt Ct-413 [**2122-10-20**] 01:42AM BLOOD Glucose-115* UreaN-53* Creat-1.0 Na-141 K-4.4 Cl-111* HCO3-23 AnGap-11 [**2122-10-20**] 01:42AM BLOOD Calcium-8.1* Phos-2.7 Mg-2.3 [**2122-10-10**] 12:00AM BLOOD HEPARIN DEPENDENT ANTIBODIES- NEGATIVE  MICROBIOLOGY: [**2122-10-11**]: Mini-BAL: STAPH AUREUS COAG +.
Suprapubic Foley catheter in the urinary bladder and air in the urinary bladder, presumably from catheter placement; correlate clinically.
Multiple maxillofacial fractures including the posterior sphenoid sinus, anterior and posterior frontal sinus, ethmoidal air cells, nasal bone, medial wall of the right maxillary sinus and anterior wall of the left maxillary sinus and nasal bones .
Suspected T2 vertebral body fracture (seen on concurrent cervical spine MRI) is not apparent by CT. 2.
Compression deformities involving the T11, T12, and L1 vertebral bodies.
Mild-to-moderate loss of height of the L1 vertebral body, with a Schmorl's node with an acute component of marrow edema in the L1 vertebral body.
Multilevel disc and facet degenerative changes in the lumbar spine with mild foraminal narrowing at L4 and L5 levels.
Diffusely altered signal intensity in the thecal sac, may relate to pulsation artifacts; however, blood products cannot be completely excluded given the presence of subarachnoid and intraventricular hemorrhage on the prior CT head study.
Otherwise, no change of the intraparenchymal, subarachnoid and subdural hemorrhage.
Current labs:  [**2122-10-23**] 04:27AM BLOOD WBC-21.4* RBC-2.94* Hgb-8.8* Hct-27.6* MCV-94 MCH-29.7 MCHC-31.7 RDW-16.1* Plt Ct-546* [**2122-10-22**] 04:45AM BLOOD WBC-20.1* RBC-2.89* Hgb-8.6* Hct-26.6* MCV-92 MCH-29.9 MCHC-32.5 RDW-16.6* Plt Ct-473* [**2122-10-23**] 04:27AM BLOOD Plt Ct-546* [**2122-10-22**] 04:45AM BLOOD Plt Ct-473* [**2122-10-23**] 04:27AM BLOOD Gran Ct-2573 [**2122-10-22**] 04:45AM BLOOD Gran Ct-3618 [**2122-10-23**] 04:27AM BLOOD Glucose-116* UreaN-46* Creat-0.9 Na-142 K-5.6* Cl-110* HCO3-23 AnGap-15 [**2122-10-22**] 01:38PM BLOOD Na-144 K-5.6* Cl-112* [**2122-10-22**] 04:45AM BLOOD Glucose-119* UreaN-47* Creat-0.9 Na-144 K-5.4* Cl-112* HCO3-21* AnGap-16 [**2122-10-21**] 12:51AM BLOOD Glucose-133* UreaN-51* Creat-1.0 Na-143 K-4.7 Cl-112* HCO3-20* AnGap-16 [**2122-10-23**] 04:27AM BLOOD Calcium-8.5 Phos-3.4 Mg-2.5 [**2122-10-22**] 04:45AM BLOOD Calcium-8.6 Phos-3.2 Mg-2.5  Brief Hospital Course: Patient was transferred from OSH via [**Location (un) **] intubated and sedated.
STAT trauma protocol was initiated on arrival to [**Hospital1 18**] ED.
Patient was tachycardic/hypotensive despite crystalloid fluid resuscitation.
This was found to be grossly stable on interval imaging during admission.
Seizure prophylaxis was administered per neurosurgical recommendation.
Throughout hospital course patient was given pain medication with good effect and adequate relief.
Tylenol and narcotics initially administered via IV and then transition to enteral with good effect.
Beta blockade was initiated following confirmation of adequate pain control and stable hematocrit.
At time of discharge patient is on stable dose of metoprolol with no cardiac issues.
Bronchoscopy was performed that demonstrated thick secretions and treatment was initiated for VAP.
Given inability to wean from ventilatory support a tracheostomy was placed [**10-14**].
Procedure was tolerated well and remains in good position at time of discharge.
At time of discharge patient tolerating T-piece supplemental oxygen with persistent requirement for Q2-3 hour suctioning/pulmonary toilet.
GI/GU: Patient was NPO with IVF at time of admission.
Enteral feeding was initiated [**10-9**] with appropriate recommendations made by nutrition service.
These were well tolerated and bowel regimen was given with good effect.
Enteral access via PEG tube was obtained [**10-14**] given expectation for long term inability to tolerate po intake.
At time of discharge patient on stable enteral feeding regimen and passing flatus/BMs appropriately.
Patient was admitted with suprapubic catheter in place related to MS.
Following initial resuscitation lasix was utilized to assist in diuresis of massive volume previously required for cardiovascular support.
At time of discharge patient with adequate urine output via pre-existing suprapubic catheter.
Nasal bone fracture was reduced at the bedside [**10-8**].
[**10-9**] hematocrit was persistently low without appropriate increases seen on prior day's transfusions.
An IVC filter was placed [**10-14**] given likelihood of protracted immobility and multiple orthopedic injuries.
Heparin products were briefly held related to this but resumed when negative test was found.
ID: Patient had recently completed a course of antibiotics for UTI at time of admission.
Given desaturations and CXR findings at this time VAP protocol was initiated with triple antibiotic therapy (vancomycin, cefepime and cipro).
Cefepime was discontinued [**10-15**].
At time of discharge patient is completing 14 day course of vancomycin and fluconazole and had been afebrile for over 72 hours.
Vancomycin and fluconazole have been discontinued.
Disposition: Patient was actively screened for appropriate post-hospital care and was accepted to facility.
At the time of discharge on [**2122-10-23**], the patient was doing well, afebrile with stable vital signs, tolerating enteral feeding, bedbound, voiding via suprapubic catheter, and pain was well controlled.
Please repeat potassium [**10-23**] and [**10-24**]  Patient was not started on home lasix dose while hospitalized because of borderline creatinine.
Please resume 40 mg lasix daily ( records unclear as to home dose....40 mg daily or 40 mg [**Hospital1 **]) Continue to monitor lytes/creat.)
Medications on Admission: [**Last Name (un) 1724**]: Copaxone, Lasix, Lexapro 40', ASA 81', Simvastatin  Discharge Medications: 1. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) ml PO BID (2 times a day).
2. amantadine 100 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
3. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain/fever.
5. glatiramer 20 mg Kit Sig: One (1) Kit Subcutaneous daily ().
6. baclofen 10 mg Tablet Sig: One (1) Tablet PO Q AM ().
7. chlorhexidine gluconate 0.12 % Mouthwash Sig: Fifteen (15) ML Mucous membrane [**Hospital1 **] (2 times a day).
8. insulin regular human 100 unit/mL Solution Sig: One (1) per sliding scale Injection ASDIR (AS DIRECTED).
9. glucagon (human recombinant) 1 mg Recon Soln Sig: One (1) mg Recon Soln Injection Q15MIN () as needed for hypoglycemia protocol.
10. levothyroxine 88 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
11. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
12. heparin (porcine) 5,000 unit/mL Solution Sig: 5000 (5000) units Injection [**Hospital1 **] (2 times a day).
13. bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal DAILY (Daily) as needed for constipation.
14. metoprolol tartrate 50 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours): hold for systolic bp <110, hr <60.
15. famotidine 20 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours).
16. dextrose 50% in water (D50W)     Syringe Sig: 12.5 g Intravenous PRN (as needed) as needed for hypoglycemia protocol.
17. neutra-phos  Sig: One (1) packet  once a day: please continue to monitor phos.
Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.
Traumatic brain injury (Left frontal subdural hematoma, scattered frontotemporal subarrachnoid hemorrhage) 2.
Multiple maxillofacial fractures including the posterior sphenoid sinus, anterior and posterior frontal sinus, ethmoidal air cells, nasal bone, medial wall of the right maxillary sinus and anterior wall of the left maxillary sinus and nasal bones   Discharge Condition: Mental Status: Confused - always.
Level of Consciousness: Lethargic and not arousable.
Please take any new medications as prescribed.
Please take the prescribed analgesic medications as needed.
Continue nursing care, enteral feeding, physical therapy per attached.
Call ([**Telephone/Fax (1) 88**] at the time of discharge to arrange an appointment to be seen and to have a non-contrast CT scan of the head on the day of your appointment.
